1Hebert PC, Wells G, Blajchman MA, et al. Amulticenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med, 1999,340:409-417.
2Hebert PC,Yetisir E,Martin C,et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med, 2001,29: 227-234.
3Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA, 2002,288:1499-1507.
4Isbister JP. Is the clinical significance of blood storage lesions underestimated? TATM, 2003,5: 356-362.
5Gan TJ. Intraoperative fluid management and choice of fluid. ASA 54th Ann Refresher Course Lectures, San Francisco, 2003. 236.
6McIlroy DR,Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg,2003,96:1572-1577.
7Friedman Z,Berkenstadt H,Preisman S,et al. A Comparison of lactated Ringer' s solution to hydroxyethy starch 6 % in a model of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg, 2003,96:39-45.
8Lang K,Boldt J,Suttner S,et al. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg, 2001,93: 405-409.
9Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients:Systematic review of randomized controlled trials. BMJ, 1998,317:235-240.
10Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0. 4 (6%,500ml) in mild-to-servere renal impairment. Anesth Analg, 2002,95: 544-551.
二级参考文献13
1Prough DS. Perioperative fluid managenent. 51th Annual Refresher Cousse Lectures P121, Amer Soc Anesthesiologister, 2000, San Francisco, USA.
2Prough DS,Svensen C. Current concepts in perioperative fluid management. 2001 Review Course lectures P70-77,75th Clinical and Scientific Congress of IARS,Ft Lauderdale, UAS.
3Svensen C, Hahn RG. Volume kinnries of ringer solution,dextran 70, and hypertonie saline in male volunteers. Anesthesiology, 1997,87: 204-212.
5Lang K, Boldt J,Suttner S, et al. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal suygery. Anesth Analg, 2001,93 : 405-409.
6Pearl RG. Treatment to shock-1998. 1998 Review Course Lectures P75-84, 72nd Clinical Scientific Congress of IARS,Orlando USA.
7Haisch G,Boldt J,Krebs C,et al. The influence of intravascular volume therapy with a new hydroxyethyl starch preperation(6% HES 130/0.4)on coagulation in patients undergoing major aldominal surgery. Anesth Analg, 2001,92:565-571.
8Stogermuler B, Stark J,Willschke H,et al. The effect of hydroxyethl starch 200KD on platelet function. Anesth Analg, 2000,91:823-827.
9Boldt J, Heesen M, Muller M, et al. The effects of albumin versus hydroxyethl starch solution on cardiorespiratory and circulatory variables in critically ill patients.Anesth Analg, 1996,83 : 254-261.
10Vogt NH, Bothner U, Lerch G, et al. Large-dose adminstration of 6% hydroxyethl starch 200/0.5 for total hip arthroplasty: plasma homeostasis, hemosgasis, and renal function compared to use of 5% human albumin. Anesth Analg, 1996,83:262-268.
